openPR Logo
Press release

Low Dosage Hydrate Inhibitors Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026

04-01-2016 02:15 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Low Dosage Hydrate Inhibitors Market Volume Analysis,

Future Market Insights has announced the addition of the “Low Dosage Hydrate Inhibitors Market: Global Industry Analysis and Opportunity Assessment 2016 - 2026" report to their offering.

Low dosage hydrate inhibitors are the products used to inhibit the formation of gas hydrates in offshore hydrocarbon drilling and production operations. Gas hydrates are basically ice-like solids that are formed by combination of water and natural gas at high pressure and low temperature. Gas hydrates create severe flow problems in oil and gas drilling and production operations. It, thus, becomes very important to remove and prevent the formation of these gas hydrates in order to have efficient flow of hydrocarbons.

Various technologies have been developed and used over the time to prevent the gas hydrates formation, such as: environmental inhibitor, thermodynamic inhibitor and low dosage hydrate inhibitors. Developed in 1990s, low dosage hydrate inhibitor is comparatively a recent technology developed as an alternative to thermodynamic inhibitors for avoiding gas hydrates from creating any flow related problem.

There are several advantages of low dosage hydrate inhibitor. They are given below:

Low Dosage
Lower Capital Costs
Lower Chemical Costs
Lower Transportation Costs
Lower Storage Costs
Smaller Pumps
Less Maintenance
Effective at Severe Conditions
Effective During Extended Shut
Total System Approach to Ensure Products are Total System Approach to Ensure Products are Compatible with Production System Compatible with Production System

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1298

Rising consumption of crude oil has led the global companies to produce more oil. Low production costs has become a necessity of market players in order to increase their profit margins. Utilization of low dosage hydrate inhibitor, because of so many advantages, is very facilitative for market players that leads to increased profit margins. Because of so many advantages and growing consumption of oil, low dosage hydrate inhibitor market is expected to boost up over the period of 2015-2025.

Drivers and Restraints

High consumption of crude oil all over the world is leading the market players to produce more crude oil. For cost effective and continuous production of crude oil, use of low dosage hydrate inhibitor has become a very important prospect of complete oil drilling and production process.

Population growth and industrialization are the major microeconomic drivers for this market. Growing population and rapid industrialization create huge demand for energy. Growing energy demand leads to higher production of oil which, in turn, leads to the growth of low dosage hydrate inhibitors.

Market Segmentation

The global low dosage hydrate inhibitor market is basically segmented on the basis of type.

On the basis of type, the low dosage hydrate inhibitor market is segmented as the following:

Anti-Agglomerate (AA) inhibitors
Kinetic Hydrate Inhibitors (KHI)

Anti-Agglomerate Inhibitors: These inhibitors keep the hydrates in a slurry and prevent them from adhering to each other.

Kinetic Hydrate Inhibitors: These type of inhibitors prevent the formation of hydrates for a longer period of time or hold them still for that period.

Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1298

The production process of low dosage hydrate inhibitor is technologically well advanced and innovation in the use of these products is on-going. With their highly foreseen benefits, low dosage hydrate inhibitors ensure a great scope of application in the oil and gas industry.

Regional Outlook

Global low dosage hydrate inhibitors market is segmented into seven main regions, which are North America, Latin America, Middle East & Africa, Western Europe, Eastern Europe, Asia Pacific and Japan. North America and Middle East and Africa are the prime regions in the global low dosage hydrate inhibitor market. Additionally, significant growth is expected in North America for these products over the period of 2015-2025.

Market Players

Ashland, Halliburton and NALCO (ECOLAB COMPANY) etc. are the major players in the global low dosage hydrate inhibitors market.

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Low Dosage Hydrate Inhibitors Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026 here

News-ID: 329515 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for Inhibitors

Thymidine Phosphorylase Inhibitors Market - Breaking the Cycle: Angiogenesis Inh …
Newark, New Castle, USA: The "Thymidine Phosphorylase Inhibitors Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Thymidine Phosphorylase Inhibitors Market: https://www.growthplusreports.com/report/thymidine-phosphorylase-inhibitors-market/8826 This latest report researches the industry structure,
CGRP Inhibitors Market - Break Free from Migraine: CGRP Inhibitors Redefining Re …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global CGRP Inhibitors Market. CGRP Inhibitors Market: https://www.growthplusreports.com/report/cgrp-inhibitors-market/9155 The CGRP Inhibitors Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts
Crude Oil Flow Improvers Market by Type (Paraffin Inhibitors, Asphaltene Inhibit …
Global Crude Oil Flow Improvers Market was valued at $1,282 million in 2016, and is anticipated to reach $1,920 million, growing at a CAGR of 5.7% from 2017 to 2023. Crude oil is one of the most actively traded commodities with a stable growth rate globally. It is extracted from remote locations and needs to be transported through pipelines. Transportation of crude oil via pipeline is relatively difficult, owing to
Immune Check Point Inhibitors Market Immune Check Point Inhibitors Clinical Pipe …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Immune Checkpoint Inhibitors- Introduction to Next Generation Cancer Immunotherapy 1.1 Overview 1.2 History- From Tragedy to Breakthrough Major Immune Checkpoints Proteins 2.1 Role of Cytotoxic T lymphocyte Antigen-4 (CTLA-4) in Cancer Development 2.2 Role of Programed Cell Death Protein 1 (PD1) in Cancer Development Mechanism of Action of Immune Checkpoint Inhibitors 3.1 Cytotoxic T lymphocyte Antigen-4
Global Immune Check Point Inhibitors Market & Immune Check Point Inhibitors Clin …
Immunotherapy represents a paradigm shift in oncology therapy along the multiple fronts. Although, targeted therapy upgrades the underlying signaling defect which results in oncogenesis within the tumor. The immune checkpoint blockade is fundamentally a therapy which directed at the patient's native immune system to tilt the immune homeostasis away from self-tolerance towards cytotoxicity, with the goal of inducing antitumor immunity. The immune checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab